US drugmaker Bristol Myers Squibb buys Mirati for $4.8bn

by

US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics.

Leave A Comment

Your email address will not be published. Required fields are marked *